Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FORCE Trial Pilot: Fresubin Supportan in Head and Neck Cancer
NCT07180576Phase 2Not yet recruiting
- Start
- Jun 2027
- Primary completion
- May 2028
01
Overview
Phase 2, open-label, single-arm trial in head and neck squamous cell carcinoma (HNSCC). Primary endpoints: Recruitment rate at 18 months, Adherence Rate and 4 more. Planned start Jun 2027; status: not yet recruiting.
02
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT07180576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07180576.